Humanized Mouse Model Market Size Anticipated to Reach $86.98 Million by 2026
Increasing Number of Research and Development Activities With Increasing Need for Early-stage Diagnose of Various Types of Cancer & Cardiovascular Diseases Are Also Driving Regional Market Growth.
Hyderabad, India – July 17, 2021 /MarketersMedia/ —
Humanized Mouse Model Market size was valued at $83.29 million in 2020, and is anticipated to reach $86.98 million by the end of 2026 growing at a CAGR of 8.2% during the forecast period 2021-2026. The humanized mouse model industry growth rate is attributed to the growing incidences of chronic disorders and increasing demand for effective therapeutic drugs and is anticipated bringing new opportunities. Basic science, safety evaluation for large molecule therapeutics, simulation of some human-specific infectious diseases, and efficacy testing of immunotherapy approaches all use humanised mouse models. In both cells and tissues, the human protein is expressed, while the mouse protein is silenced. Humanized mouse models are used to study cancer genetics, Auto immune diseases, regenerative medicine, human hematopoiesis, infectious diseases, transplantation, and autoimmunity. They improve the translational value of preclinical research by allowing researchers to gain a better understanding of disease pathways. Apart from this, the model requires accurate risk assessment and thorough analysis to preserve the physiological expression and regulation of the human gene inserted into the mouse genome. The genes and proteins of both the mouse and the human are examined for accuracy and structure in order to determine the optimum expression and functionality of the human protein in a mouse environment. Nonetheless, speedy technological advancements have been seen in the area, leading to the development of transgenic mouse, knock-in mouse, and knock-out mouse.
Humanized Mouse Model Market Segment Analysis – By Application
In 2020, on the basis of application, oncology segment accounted for the largest segmental revenue of the humanized mouse model market. The oncology segment held the largest market on account of the rising number of cancer research activities. This segment is projected to witness healthy growth throughout the forecast period 2021-2026 with a CAGR of 8.80%. This is owing to its vast range of applications in a variety of oncological fields coupled with advanced healthcare facilities and growing healthcare expenditure. Furthermore, there is an increasing innovation to develop humanized mouse models tailored to meet the specific needs of cancer research. All these factors are anticipated to fuel market growth during the forecast period 2021-2026.
Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=507021
Report Price: $ 5900 (Single User License)
Humanized Mouse Model Market Segment Analysis – By End Users
On the basis of end users, contract research organizations (CROs) segment accounted for the largest segmental revenue of the humanized mouse model market in 2020. The largest share can be attributed to the rise in the number of pharmaceutical companies outsourcing their preclinical studies to CROs. In addition, contract research organisations (CROs) are focusing on using these models to produce new drugs in order to gain a profitable market share. They are also interested in drug toxicity assessment and preclinical analysis. Furthermore, biotechnology corporations fund basic and advanced medical and veterinary research programs.
Humanized Mouse Model Market Segment Analysis – By Geography
North America is the major region dominating the Humanized Mouse Model market with a market share of 35.60% in the year 2020. This can be attributed to the growth in this regional segment and can primarily be attributed to growing biomedical research, preclinical activities by CROs and pharmaceutical R&D, continued and responsible use of animals ensured by animal care organizations, increasing monoclonal antibody production in the US along with growing stem cell research, and government support for the development of protein drugs in Canada have fueled the regional market. Moreover, increasing number of research and development activities with increasing need for early-stage diagnose of various types of cancer & cardiovascular diseases are also driving regional market growth.
Humanized Mouse Model Market Drivers
Rising Demand For Personalized Medicine
The humanized mouse model market is poised to receive upswing owing to the rising demand for personalized medicine as these medicines are designed through the use of animal models, particularly mice models. Human tissues are transplanted into immune-deficient models, and the disease expression is registered. Following that, the model is treated with a variety of drugs or gene therapies in order to find the most appropriate therapy, resulting in appropriate or customized medication for patients and thereby augmenting factors that will impact the global market. Furthermore, advancements in genomics, proteomics, and metabolomics; the completion of the Human Genome Project; the growth of tailored diagnostics and therapeutics; and the increasing focus on wellbeing, wellness, and prevention are all driving demand for personalised medicine.
Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=507021
Humanized Mouse Model Market Challenges
High Cost Of Humanized Models
Despite several drivers, one of the major factor hindering is the high cost of humanized models which is restraining the its usage in experiments as humanized models used in experiments can cost thousands of dollars even in the case of a single patient. Moreover, using humanized models in government-funded basic research can also be cost-prohibitive thereby, challenging the regional market growth.
Humanized Mouse Model Market Landscape
Humanized mouse model market top 10 companies are The Jackson Laboratory, Taconic Biosciences, Inc., Harbour BioMed, HuMurine Technologies, Inc., Vitalstar Biotechnology Co. Ltd., Crown Bioscience, Inc., ingenious targeting laboratory, Axenis S.A.S., TRANS GENIC, Inc., genOway S. A. and others.
Acquisitions/Product Launches
In April 2019, Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the launch of TruBIOME®, a first of its kind solution enabling the generation and maintenance of mice with custom microbiome profiles.
Key Takeaways
North America dominated the Humanized Mouse Model market with a share of 35.60% in the year 2020.
The factors such as growing aging population and rising number of diagnostic imaging are amongst the major factor projected to impel growth of Humanized Mouse Model market.
Additionally, factors such as development of automated diagnostic imaging systems for laboratories and hospitals to provide efficient, accurate, and error-free diagnosis and increasing government investments are to create opportunities paving a way for the growth in the market during forecast period 2021-2026.
Related Reports :
A. Knockout Mice Model Market
https://www.industryarc.com/Report/15098/knockout-mice-model-pricing-analysis-market.html
B. Humanized Mouse And Rat Model Market
https://www.industryarc.com/Research/Humanized-Mouse-And-Rat-Model-Market-Research-505621
For more Lifesciences and Healthcare related reports, please click here
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.
Contact Info:
Name: Venkat Reddy
Email: Send Email
Organization: IndustryARC
Phone: (+1) 970-236-3677
Website: https://www.industryarc.com/
Source: MarketersMedia
Release ID: 89036755
Copyright © 1999-2013 SproutNews.com
